Evidence map›Paper›PMID 31878985›Full record

ReviewGenetics research2019

Transmembrane emp24 domain proteins in development and disease.

Rachel Aber, Wesley Chan, Sevane Mugisha, Loydie A Jerome-Majewska

Open access · goldAbstract readReview
In one paragraph

Review in Genetics research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rachel AberDepartment of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada.
Wesley ChanDepartment of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada.ORCID 0000-0001-9805-1700
Sevane MugishaDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
Loydie A Jerome-MajewskaDepartment of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-5047-4058
McGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulated transport through the secretory pathway is essential for embryonic development and homeostasis. Disruptions in this process impact cell fate, differentiation and survival, often resulting in abnormalities in morphogenesis and in disease. Several congenital malformations are caused by mutations in genes coding for proteins that regulate cargo protein transport in the secretory pathway. The severity of mutant phenotypes and the unclear aetiology of transport protein-associated pathologies have motivated research on the regulation and mechanisms through which these proteins contribute to morphogenesis. This review focuses on the role of the p24/transmembrane emp24 domain (TMED) family of cargo receptors in development and disease.

Indexed as

AnimalsCarrier ProteinsHumansIntracellular MembranesMembrane ProteinsProtein TransportTransport VesiclesVesicular Transport ProteinsCarrier ProteinsMembrane ProteinsVesicular Transport Proteinscargo receptordevelopmentdiseasep24TMED

Identifiers

PMID31878985
PMCPMC7045115
OpenAlexW2998605097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.